MORGAN STANLEY - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,635
-24.5%
60,226
+2.3%
0.00%
Q2 2023$82,978
-6.6%
58,850
+5.3%
0.00%
Q1 2023$88,859
-1.8%
55,886
-9.8%
0.00%
Q4 2022$90,492
-67.9%
61,981
-6.4%
0.00%
Q3 2022$282,000
-17.8%
66,192
-25.0%
0.00%
Q2 2022$343,000
+6.5%
88,296
+30.4%
0.00%
Q1 2022$322,000
-84.7%
67,702
-88.2%
0.00%
Q4 2021$2,102,000
+730.8%
576,077
+1728.8%
0.00%
Q3 2021$253,000
-37.8%
31,501
-12.4%
0.00%
Q2 2021$407,000
+8.5%
35,946
-11.4%
0.00%
Q1 2021$375,00040,5940.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders